Gilead Financial News

24.07 / 13:41
Provident FIVE Digital Manufacturing Platform Software Gilead Deal Cognizant extends partnership with biopharma firm Gilead, estimated deal size at $800 million
biopharmaceutical company Gilead Sciences for an additional five years, including renewal and expansion of Cognizant's services, for a total expected value of $800 million. Under the agreement, the NASDAQ-listed IT firm will manage Gilead’s global IT infrastructure, platforms, applications and advanced analytics, and lead initiatives to accelerate its digital transformation.

what you should know about Gilead

What is Gilead and why is it gaining attention?

Gilead is a trending topic that interests a wide audience. On our site, we regularly publish updates related to this subject.

Where can I find the latest updates on Gilead?

All new posts about Gilead can be found in the dedicated section. We publish information as it becomes available.

How can I verify the accuracy of information on Gilead?

We rely on trusted sources to ensure that the information about Gilead is reliable and valuable for our readers.